Sarah-Anne Nicholas: Excited to Share My First-Author Publication from My PhD Research
Sarah-Anne Nicholas, Post Doctoral Fellow at Boehringer Ingelheim, shared a post on LinkedIn, about a recent article she and her colleagues co-authored, published in AHA Journals:
“Excited to share my first-author publication featuring research from my PhD.
It feels amazing to see this work out in the world, especially because it supports a shift in thinking about the role endothelial cells play in immune responses in cardiovascular disease – not just as gatekeepers regulating immune cell infiltration, but as active mediators of T cell phenotype and survival.
I am incredibly grateful to my PI and mentor Patrick Murphy for his guidance, patience, and unwavering support.
I am also deeply thankful for the help of my co-authors and the many hands that contributed along the way.
It was a long road – but a journey defined by challenges met with grit and determination that ultimately led to this pretty remarkable success.”
Title: Endothelial Elavl1 Is Required for CD8 T-Cell Persistence in Atherosclerosis
Authors: Sarah-Anne E Nicholas, Stephen B Helming, Antoine Ménoret, Christopher L Pathoulas, Maria M Xu, Jessica Hensel, Amy L Kimble, Brent Heineman, Evan R Jellison, Bo Reese, Beiyan Zhou, Annabelle Rodriguez-Oquendo, Anthony T Vella, Patrick A Murphy
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 06:57Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?